Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy.
Contraception
; 75(6 Suppl): S123-9, 2007 Jun.
Article
em En
| MEDLINE
| ID: mdl-17531603
ABSTRACT
Hemostatic disorders in women are frequently associated with long-standing menorrhagia. This leads to significant morbidity and adversely affects quality of life. Management of these women poses a particular challenge; medical treatments may be contraindicated, and surgery carries additional risks. The levonorgestrel intrauterine system (LNG-IUS) has been shown to be highly efficacy in reducing menstrual blood loss in women with normal coagulation. It is also a reliable and reversible contraceptive. Data on the use of this system in women with bleeding disorders or those receiving anticoagulant therapy are limited. Analysis of data from four reported studies suggests that LNG-IUS is a viable and safe option for the management of menorrhagia in these women. Whether the underlying hemostatic disorders lead to a shorter duration of action or prolonged irregular bleeding/spotting post insertion is unknown and requires large prospective studies. Proper counselling remains crucial for patients' satisfaction.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Levanogestrel
/
Anticoncepcionais Femininos
/
Transtornos Herdados da Coagulação Sanguínea
/
Dispositivos Intrauterinos Medicados
/
Menorragia
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
Idioma:
En
Revista:
Contraception
Ano de publicação:
2007
Tipo de documento:
Article
País de afiliação:
Reino Unido